D
David Bergqvist
Researcher at Uppsala University
Publications - 120
Citations - 14437
David Bergqvist is an academic researcher from Uppsala University. The author has contributed to research in topics: Low molecular weight heparin & Heparin. The author has an hindex of 40, co-authored 120 publications receiving 13694 citations. Previous affiliations of David Bergqvist include Uppsala University Hospital & Lund University.
Papers
More filters
Journal ArticleDOI
Trousseau's syndrome - what is the evidence? A population-based autopsy study.
TL;DR: The relationship between cancer and PE was evaluated and it was concluded that the risk of PE in cancer patients depends not only on the cancer site and spread but also on the histological type.
Journal ArticleDOI
Intimal Hyperplasia Recurs After Removal of PDGF-AB and -BB Inhibition in the Rat Carotid Artery Injury Model
Olli Leppänen,Nebojsa Janjic,Mari-Anne Carlsson,Kristian Pietras,Max Levin,Chandra Vargeese,Louis S. Green,David Bergqvist,Arne Östman,Carl-Henrik Heldin +9 more
TL;DR: The findings confirm a role of PDGF B-chain in intimal hyperplasia, but the successful use ofPDGF antagonists may require either prolonged treatment or combination therapy with other agents.
Journal ArticleDOI
Influence of diagnostic criteria on the prevalence of abdominal aortic aneurysm
TL;DR: In a region in which residents have a high risk for cardiovascular disease, this study found the highest prevalence of abdominal aortic aneurysm ever reported within a population, with a 10-fold variation.
Journal ArticleDOI
Mesenteric venous thrombosis with transmural intestinal infarction: a population-based study.
TL;DR: Portal vein thrombosis, systemic venous thromboembolism and obesity were associated with fatal MVT, and obesity was an independent risk factor for fatal MVt.
Journal ArticleDOI
Treatment of vascular Ehlers-Danlos syndrome: a systematic review.
TL;DR: Vascular EDS is a serious disorder with high mortality, which does not seem to have been influenced by new treatment methods, and should be used only when necessary, primarily to save the patients' life.